BioNxt Solutions Inc. (CSE:BNXT)
Canada · Delayed Price · Currency is CAD 0.5500
-0.0400 (-6.78%)
Jul 18, 2025, 3:44 PM EDT
BioNxt Solutions Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 0.02 | 0.03 | 0.37 | 0.3 | 0.29 | 0.35 | Upgrade | |
Revenue Growth (YoY) | -88.95% | -92.75% | 25.15% | 3.82% | -17.11% | 66.09% | Upgrade |
Cost of Revenue | - | - | - | 0.71 | 0.09 | - | Upgrade |
Gross Profit | 0.02 | 0.03 | 0.37 | -0.41 | 0.2 | 0.35 | Upgrade |
Selling, General & Admin | 2.2 | 2.41 | 3.36 | 3.7 | 8.97 | 8.32 | Upgrade |
Research & Development | 1.14 | 1.43 | 2.55 | 2.11 | 3.34 | 3.24 | Upgrade |
Operating Expenses | 4.97 | 4.48 | 6.73 | 6.16 | 16.41 | 15.05 | Upgrade |
Operating Income | -4.95 | -4.45 | -6.36 | -6.57 | -16.21 | -14.7 | Upgrade |
Interest Expense | -1.02 | -0.99 | -1.04 | -1.14 | -0.73 | -0.3 | Upgrade |
Interest & Investment Income | 0 | 0 | - | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.39 | 0.12 | 0.04 | 0.14 | -0.1 | -0.17 | Upgrade |
Other Non Operating Income (Expenses) | -0.12 | -0.11 | -0.03 | -0.1 | -0.1 | -0.1 | Upgrade |
EBT Excluding Unusual Items | -5.69 | -5.43 | -7.39 | -7.67 | -17.14 | -15.27 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -1.64 | Upgrade |
Gain (Loss) on Sale of Assets | 0 | - | -0.05 | - | - | -0.02 | Upgrade |
Asset Writedown | - | - | -0.05 | -5.89 | -3.68 | -0.31 | Upgrade |
Other Unusual Items | -0.12 | 0.03 | -0.24 | 0.69 | 0.07 | - | Upgrade |
Pretax Income | -5.8 | -5.4 | -7.72 | -12.87 | -20.75 | -17.25 | Upgrade |
Income Tax Expense | -0.09 | -0.09 | - | -0.49 | -0.11 | -0.36 | Upgrade |
Net Income | -5.71 | -5.31 | -7.72 | -12.38 | -20.64 | -16.89 | Upgrade |
Net Income to Common | -5.71 | -5.31 | -7.72 | -12.38 | -20.64 | -16.89 | Upgrade |
Shares Outstanding (Basic) | 113 | 111 | 99 | 84 | 70 | 57 | Upgrade |
Shares Outstanding (Diluted) | 113 | 111 | 99 | 84 | 70 | 57 | Upgrade |
Shares Change (YoY) | 9.53% | 12.17% | 18.56% | 19.28% | 22.75% | 26.44% | Upgrade |
EPS (Basic) | -0.05 | -0.05 | -0.08 | -0.15 | -0.29 | -0.30 | Upgrade |
EPS (Diluted) | -0.05 | -0.05 | -0.08 | -0.15 | -0.29 | -0.30 | Upgrade |
Free Cash Flow | -3.36 | -3.03 | -5.37 | -6.23 | -12.61 | -10.36 | Upgrade |
Free Cash Flow Per Share | -0.03 | -0.03 | -0.05 | -0.07 | -0.18 | -0.18 | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | -138.28% | 69.63% | 100.00% | Upgrade |
Operating Margin | -21642.87% | -16502.86% | -1708.42% | -2210.02% | -5659.36% | -4253.64% | Upgrade |
Profit Margin | -24999.89% | -19683.18% | -2074.68% | -4160.84% | -7203.23% | -4886.32% | Upgrade |
Free Cash Flow Margin | -14713.65% | -11243.72% | -1442.32% | -2095.73% | -4400.52% | -2997.63% | Upgrade |
EBITDA | -4.85 | -4.36 | -6.19 | -6.4 | -16.03 | -14.45 | Upgrade |
D&A For EBITDA | 0.09 | 0.09 | 0.16 | 0.17 | 0.18 | 0.25 | Upgrade |
EBIT | -4.95 | -4.45 | -6.36 | -6.57 | -16.21 | -14.7 | Upgrade |
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.